Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection

Detalles Bibliográficos
Autores principales: Tanaka, Yuetsu, Takahashi, Yoshiaki, Kodama, Akira, Tanaka, Reiko, Saito, Mineki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044937/
http://dx.doi.org/10.1186/1742-4690-11-S1-O39
_version_ 1782319221193048064
author Tanaka, Yuetsu
Takahashi, Yoshiaki
Kodama, Akira
Tanaka, Reiko
Saito, Mineki
author_facet Tanaka, Yuetsu
Takahashi, Yoshiaki
Kodama, Akira
Tanaka, Reiko
Saito, Mineki
author_sort Tanaka, Yuetsu
collection PubMed
description
format Online
Article
Text
id pubmed-4044937
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40449372014-06-19 Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection Tanaka, Yuetsu Takahashi, Yoshiaki Kodama, Akira Tanaka, Reiko Saito, Mineki Retrovirology Oral Presentation BioMed Central 2014-01-07 /pmc/articles/PMC4044937/ http://dx.doi.org/10.1186/1742-4690-11-S1-O39 Text en Copyright © 2014 Tanaka et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Tanaka, Yuetsu
Takahashi, Yoshiaki
Kodama, Akira
Tanaka, Reiko
Saito, Mineki
Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection
title Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection
title_full Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection
title_fullStr Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection
title_full_unstemmed Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection
title_short Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection
title_sort neutralizing antibodies against human t cell leukemia virus type-i (htlv-1) eradicate htlv-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044937/
http://dx.doi.org/10.1186/1742-4690-11-S1-O39
work_keys_str_mv AT tanakayuetsu neutralizingantibodiesagainsthumantcellleukemiavirustypeihtlv1eradicatehtlv1incombinationwithautologousperipheralbloodmononuclearcellsviaantibodydependentcellularcytotoxicitywhilepreventingnewinfection
AT takahashiyoshiaki neutralizingantibodiesagainsthumantcellleukemiavirustypeihtlv1eradicatehtlv1incombinationwithautologousperipheralbloodmononuclearcellsviaantibodydependentcellularcytotoxicitywhilepreventingnewinfection
AT kodamaakira neutralizingantibodiesagainsthumantcellleukemiavirustypeihtlv1eradicatehtlv1incombinationwithautologousperipheralbloodmononuclearcellsviaantibodydependentcellularcytotoxicitywhilepreventingnewinfection
AT tanakareiko neutralizingantibodiesagainsthumantcellleukemiavirustypeihtlv1eradicatehtlv1incombinationwithautologousperipheralbloodmononuclearcellsviaantibodydependentcellularcytotoxicitywhilepreventingnewinfection
AT saitomineki neutralizingantibodiesagainsthumantcellleukemiavirustypeihtlv1eradicatehtlv1incombinationwithautologousperipheralbloodmononuclearcellsviaantibodydependentcellularcytotoxicitywhilepreventingnewinfection

Ejemplares similares